Gara per servizi di test per la TB

The Trust requires the provision of an Interferon Gamma Release Assay (IGRA) testing service for the detection of Mycobacterium tuberculosis infection using the T-SPOT.TB assay, which is the Trust's established standard referred test for Tuberculosis (TB) screening and diagnosis support. Based on current activity levels, the estimated annual demand is approximately 2,820 T-SPOT.TB tests. This volume is indicative only and does not constitute a guaranteed commitment. The contract will ensure continuity of a reliable, high-quality referred testing service that delivers accurate and timely results to support patient diagnosis, treatment decisions and infection control requirements.